Sagimet Research Development from 2010 to 2026
| SGMT Stock | 5.06 0.09 1.75% |
Research Development | First Reported 2010-12-31 | Previous Quarter 44.2 M | Current Value 46.4 M | Quarterly Volatility 13.6 M |
Check Sagimet Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sagimet Biosciences' main balance sheet or income statement drivers, such as Net Interest Income of 10.7 M, Interest Income of 10.7 M or Depreciation And Amortization of 18.8 M, as well as many indicators such as Price To Sales Ratio of 39.45, Dividend Yield of 0.0 or PTB Ratio of 0.86. Sagimet financial statements analysis is a perfect complement when working with Sagimet Biosciences Valuation or Volatility modules.
Sagimet | Research Development | Build AI portfolio with Sagimet Stock |
The evolution of Research Development for Sagimet Biosciences Series provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Sagimet Biosciences compares to historical norms and industry peers.
Latest Sagimet Biosciences' Research Development Growth Pattern
Below is the plot of the Research Development of Sagimet Biosciences Series over the last few years. It is Sagimet Biosciences' Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sagimet Biosciences' overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
Sagimet Research Development Regression Statistics
| Arithmetic Mean | 16,776,690 | |
| Geometric Mean | 13,159,759 | |
| Coefficient Of Variation | 81.07 | |
| Mean Deviation | 10,876,658 | |
| Median | 8,391,000 | |
| Standard Deviation | 13,601,059 | |
| Sample Variance | 185T | |
| Range | 38.2M | |
| R-Value | 0.81 | |
| Mean Square Error | 67.7T | |
| R-Squared | 0.66 | |
| Significance | 0.000079 | |
| Slope | 2,183,253 | |
| Total Sum of Squares | 2959.8T |
Sagimet Research Development History
About Sagimet Biosciences Financial Statements
Sagimet Biosciences shareholders use historical fundamental indicators, such as Research Development, to determine how well the company is positioned to perform in the future. Although Sagimet Biosciences investors may analyze each financial statement separately, they are all interrelated. The changes in Sagimet Biosciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on Sagimet Biosciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Research Development | 44.2 M | 46.4 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Sagimet Stock Analysis
When running Sagimet Biosciences' price analysis, check to measure Sagimet Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sagimet Biosciences is operating at the current time. Most of Sagimet Biosciences' value examination focuses on studying past and present price action to predict the probability of Sagimet Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sagimet Biosciences' price. Additionally, you may evaluate how the addition of Sagimet Biosciences to your portfolios can decrease your overall portfolio volatility.